Profile: OctoPlus N.V. is a drug development company. Our business activities include pharmaceutical development services, drug delivery technologies & product development. PolyActive® is a biodegradable polymeric drug delivery system for the controlled release of proteins and lipophilic small molecules. SynBiosys™ is a biodegradable polymeric drug delivery system for the controlled release of peptides and small molecules. OP-145 is a proprietary peptide for the treatment of chronic middle ear infection. GLP-1 is a metabolic hormone for the treatment of type 2 diabetes.